Palvella Therapeutics (PVLA) Other Working Capital Changes (2014 - 2026)
Palvella Therapeutics (PVLA) reported Other Working Capital Changes of $357000.0 for Q1 2026, up 260.81% on a QoQ basis from -$222000.0 in Q4 2025.
Palvella Therapeutics (PVLA) has 13 years of Other Working Capital Changes data on file, last reported at $357000.0 in Q1 2026.
- Quarterly Other Working Capital Changes changed N/A year-over-year to $357000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 164.68% YoY) and the FY2025 annual result came in at -$1.4 million, down 190.75% from the prior year.
- Other Working Capital Changes improved to $357000.0 in Q1 2026 per PVLA's latest filing, from -$222000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $19.7 million in Q1 2022 and bottomed at -$34.1 million in Q4 2023.
- The 5-year median for Other Working Capital Changes is $148500.0 (2024), against an average of $75812.5.
- The widest annual swing landed in 2023, when Other Working Capital Changes soared 3341.02%; it then tumbled 688.96% in 2025.
- Tracing PVLA's Other Working Capital Changes over 5 years: stood at -$26.4 million in 2022, then slipped by 29.08% to -$34.1 million in 2023, then soared by 103.7% to $1.3 million in 2024, then sank by 117.62% to -$222000.0 in 2025, then soared by 260.81% to $357000.0 in 2026.
- Per Business Quant, the three latest PVLA Other Working Capital Changes figures stand at $357000.0 (Q1 2026), -$222000.0 (Q4 2025), and -$182000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 357,000.00 |
| Mar 31, 2026 | 357,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Sep 30, 2025 | -182,000.00 |
| Sep 30, 2025 | -182,000.00 |
| Jun 30, 2025 | -960,000.00 |
| Jun 30, 2025 | -960,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 134,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | -54,000.00 |
| Mar 31, 2024 | -54,000.00 |
| Dec 31, 2023 | -34.08 Mn |
| Dec 31, 2023 | -34.08 Mn |
| Sep 30, 2023 | 15.52 Mn |
| Sep 30, 2023 | 15.52 Mn |
| Jun 30, 2023 | 18.89 Mn |
| Jun 30, 2023 | 18.89 Mn |
| Mar 31, 2023 | -607,000.00 |
| Mar 31, 2023 | -607,000.00 |
| Dec 31, 2022 | -26.40 Mn |
| Dec 31, 2022 | -26.40 Mn |
| Sep 30, 2022 | 451,000.00 |
| Sep 30, 2022 | 451,000.00 |
| Jun 30, 2022 | 7.29 Mn |
| Jun 30, 2022 | 7.29 Mn |
| Mar 31, 2022 | 19.65 Mn |
| Mar 31, 2022 | 19.65 Mn |
| Dec 31, 2021 | 34.78 Mn |
| Dec 31, 2021 | 34.78 Mn |
| Sep 30, 2021 | -56,000.00 |
| Sep 30, 2021 | -56,000.00 |
| Jun 30, 2021 | -43.46 Mn |
| Jun 30, 2021 | -43.46 Mn |
| Mar 31, 2021 | 9.72 Mn |
| Mar 31, 2021 | 9.72 Mn |
| Dec 31, 2020 | -14.29 Mn |
| Dec 31, 2020 | -14.29 Mn |
| Sep 30, 2020 | -5.46 Mn |
| Sep 30, 2020 | -5.46 Mn |
| Jun 30, 2020 | 6.80 Mn |
| Jun 30, 2020 | 6.80 Mn |
| Mar 31, 2020 | 13.46 Mn |
| Mar 31, 2020 | 13.46 Mn |
| Dec 31, 2019 | -19.62 Mn |
| Dec 31, 2019 | -19.62 Mn |
| Sep 30, 2019 | 12.08 Mn |
| Sep 30, 2019 | 12.08 Mn |
| Jun 30, 2019 | 831,000.00 |
| Jun 30, 2019 | 831,000.00 |
| Mar 31, 2019 | 5.92 Mn |
| Mar 31, 2019 | 5.92 Mn |
| Dec 31, 2018 | 19.37 Mn |
| Dec 31, 2018 | 19.37 Mn |
| Sep 30, 2018 | 9.21 Mn |
| Sep 30, 2018 | 9.21 Mn |
| Jun 30, 2018 | 10.32 Mn |
| Jun 30, 2018 | 10.32 Mn |
| Mar 31, 2018 | -38.91 Mn |
| Mar 31, 2018 | -38.91 Mn |
| Dec 31, 2017 | 151.65 Mn |
| Dec 31, 2017 | 151.65 Mn |
| Sep 30, 2017 | -41.49 Mn |
| Sep 30, 2017 | -41.49 Mn |
| Jun 30, 2017 | -2.87 Mn |
| Jun 30, 2017 | -2.87 Mn |
| Mar 31, 2017 | -32.91 Mn |
| Mar 31, 2017 | -32.91 Mn |
| Dec 31, 2016 | -1.14 Mn |
| Dec 31, 2016 | -1.14 Mn |
| Sep 30, 2016 | -2.95 Mn |
| Sep 30, 2016 | -2.95 Mn |
| Jun 30, 2016 | 3.93 Mn |
| Jun 30, 2016 | 3.93 Mn |
| Mar 31, 2016 | 1.19 Mn |
| Mar 31, 2016 | 1.19 Mn |
| Dec 31, 2015 | 487,169.00 |
| Dec 31, 2015 | 487,169.00 |
| Sep 30, 2015 | -628,646.00 |
| Sep 30, 2015 | -628,646.00 |
| Jun 30, 2015 | 670,153.00 |
| Jun 30, 2015 | 670,153.00 |
| Mar 31, 2015 | 727,475.00 |
| Mar 31, 2015 | 727,475.00 |
| Sep 30, 2014 | 128,146.00 |
| Sep 30, 2014 | 128,146.00 |
| Jun 30, 2014 | 72,570.00 |
| Jun 30, 2014 | 72,570.00 |
| Mar 31, 2014 | 260,096.00 |
| Mar 31, 2014 | 260,096.00 |